Why the study?
An upsurge in echovirus 30 (E30) infections was reported in Europe in 2018.
The 2018 upsurge in echovirus 30 infections in Europe was driven by the emergence and rapid turnover of two distinct genetic clades (G1 and G6) and their recombinant forms.
Authors
No takes yet. Share an insight, caveat, or question.
Monitoring E30 clades in Europe is warranted; leaves open drivers of age-specific outbreaks and clade dominance.
Benschop et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: